Healthy Clinical Trial
Official title:
WILD 5 Wellness: A 90-Day Intervention (WILD = Wellness Interventions for Life's Demands)
The purpose of this study is to explore the efficacy and feasibility of an integrated, prescriptive, and trackable wellness intervention combining five wellness elements including exercise, mindfulness, sleep, social connectedness, and nutrition.
This study involves participating in a 90-day integrated, prescriptive, trackable wellness
intervention, which includes five wellness elements: exercise, mindfulness, sleep, social
connectedness, and nutrition.
The intervention is divided into three phases (each spanning 30-days): Phase 1 - 'Boot Camp',
Phase 2 - Solidify, and Phase 3 - Sustain. Program requirements include: Implementing 5
wellness interventions daily for the first 30-days, at least 5 days for the next 30-days, and
at least 3 days for the final 30-days, documenting daily online adherence, completing daily
wellness exercises to improve mental wellness, and completing online program forms prior to
beginning the program, at 30-days, and again at 90-days.
Once eligibility is confirmed via the initial orientation/screening call, study personnel
will mail each participant a WILD 5 Wellness Workbook within one day of emailing participants
their unique identification codes plus their start dates. Participants will be instructed to
document adherence regarding their daily wellness practices and their daily wellness
exercises online via Qualtrics, an online survey software. Participants can document their
daily adherence using their computer and/or their smartphone as Qualtrics offers a mobile
version of the Participant Tracking Form. A copy of the Participant Tracking Form will also
be available in the WILD 5 Workbook so participants that prefer keeping a daily paper log can
do so, and they can then transfer their program adherence information to the online
Participant Tracking Form throughout the program. The workbook will contain the participant's
personal identification code; no personal identification will appear in the workbook in order
to protect participant confidentiality.
One day prior to a participant's start date, which will be set during the
orientation/screening call, participants will receive an automated email from an online
automated email service (MailChimp), with a reminder about their start date, and
encouragement to contact study personnel with any questions or concerns.
Participants will also receive daily motivational emails from an online automated email
service (MailChimp), which will provide general information about one of the five wellness
elements and/or one of the wellness exercises, as well as encouragement to track their
participation on a daily basis, and encouragement to contact study personnel via email with
any questions and/or concerns.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
| Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
| Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
| Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
| Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
| Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
| Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
| Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
| Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
| Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
| Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
| Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
| Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
| Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
| Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
| Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
| Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |